SAP FI/CO Business Systems Analyst - Onsite in Aliso Viejo, CA
Glaukos · Aliso Viejo, California, United States · $130K–$163K/yr
Medical Equipment Manufacturing · 1,001-5,000 employees
About the role
Design, configure, and support SAP S/4HANA Finance and Controlling solutions within a GxP-regulated Life Sciences environment. Act as a liaison between Finance, Quality, Compliance, and IT to ensure scalable and audit-ready financial systems.
What they look for
Requirements
Requires deep functional expertise in SAP FICO combined with technical ABAP development capabilities. Experience with data migration, integrations, and compliance in a regulated industry is essential.
Full description
Senior FI/CO SAP Business Analyst (Functional & Technical)
The Senior FI/CO SAP Business Analyst is a senior‑level functional and technical expert responsible for designing, configuring, enhancing, and supporting SAP S/4HANA Finance and Controlling solutions within a Life Sciences (GxP‑regulated) environment. This role serves as a critical liaison between Finance, Controlling, Quality, Compliance, and IT, ensuring SAP solutions are financially accurate, compliant, audit‑ready, and scalable.
This position requires deep functional expertise in SAP FICO, combined with hands‑on technical and development capabilities, including ABAP‑supported enhancements, integrations, data migration, and reporting. The ideal candidate understands that in Life Sciences, process design, validation, and compliance are inseparable from system delivery.
Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible.
Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.
Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.
Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.
All offers of employment are contingent upon the successful completion of a background check, including successfully passing a drug screen, based on the position and local regulations.
